cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2007; 50:852-858, doi:10.1016/j.jacc.2007.04.076 (Published online 10 August 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mäki-Petäjä, K. M.
Right arrow Articles by Wilkinson, I. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mäki-Petäjä, K. M.
Right arrow Articles by Wilkinson, I. B.

Ezetimibe and Simvastatin Reduce Inflammation, Disease Activity, and Aortic Stiffness and Improve Endothelial Function in Rheumatoid Arthritis

Kaisa M. Mäki-Petäjä, BSc*,1,*, Anthony D. Booth, MD, MRCP2,*, Frances C. Hall, DPhil, FRCP{dagger},3, Sharon M.L. Wallace, BA, RN*, John Brown, DM, FRCP{ddagger}, Carmel M. McEniery, PhD* and Ian B. Wilkinson, DM, FRCP2,*

* Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom
{dagger} Department of Clinical Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge, United Kingdom
{ddagger} Trinity College, University of Cambridge, Cambridge, United Kingdom.


Figure 1
View larger version (4K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 The Study Design

Following 2-week placebo run-in, patients received simvastatin or ezetimibe in a randomized double-blinded manner, each for 6 weeks, with a 6-week washout between the drugs.

 

Figure 2
View larger version (7K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Effect of 10 mg Ezetimibe and 20 mg Simvastatin on Aortic PWV

Measurements were taken after 6 weeks of each treatment. Bars show mean and standard error of mean (n = 20). The omnibus significance for the trend was p = 0.001. The significance was determined by 2-way repeated measures analysis of variance with post hoc testing with Bonferroni adjustment. PWV = pulse wave velocity.

 

Figure 3
View larger version (6K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Effect of 10 mg Ezetimibe and 20 mg Simvastatin on FMD

Measurements were taken after 6 weeks of each treatment. Bars show mean and standard error of mean (n = 20). The omnibus significance for the trend was p < 0.001. The significance was determined by 2-way repeated measures analysis of variance with post hoc testing with Bonferroni adjustment. FMD = flow-mediated dilation.

 

Figure 4
View larger version (6K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Relationship Between Baseline ESR and Change in Aortic PWV Following Ezetimibe and Simvastatin

The change in aortic pulse wave velocity (PWV) following drug treatment was significantly associated with the baseline erythrocyte sedimentation rate (ESR); r = –0.416; p = 0.008. Solid circles = ezetimibe; open circles = simvastatin.

 




 
  cardiology careers collections past issues search home